Marked left ventricular hypertrophy mimicking hypertrophic cardiomyopathy associated with steroid therapy for congenital adrenal hyperplasia

Journal of Cardiovascular Medicine

Volumn 8, Issue 6, 2007, Pages 465-467

  Scirè, Giuseppe ^a,b   D'Anella, Giorgio ^b   Cristofori, Laura ^a   Mazzuca, Valentina ^b   Cianfarani, Stefano ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

Congenital adrenal hyperplasia; Hypertrophic cardiomyopathy; Left ventricle; Mitral valve

Indexed keywords

FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; PROPRANOLOL;

ADRENAL HYPERPLASIA; ARTICLE; BLOOD PRESSURE; CASE REPORT; CHILD; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE HYPERTROPHY; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE;

ADRENAL HYPERPLASIA, CONGENITAL; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPERTROPHY, LEFT VENTRICULAR; INFANT; INFANT, NEWBORN; MALE;

EID: 34248547634     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3280104269     Document Type: Article

References (11)

1. Fritz KI, Bhat AM. Effect of beta-blockade on symptomatic dexamethasone-induced hypertrophic obstructive cardiomyopathy in premature infants: three case reports and literature review. J Perinatol 1998; 18:38-44.
2. Alpert BS. Steroid-induced hypertrophic cardiomyopathy in an infant. Pediatr Cardiol 1984; 5:117-118.
3. Schuster JD, Gidding SS. Possible relationship of acquired hypertrophic cardiomyopathy to corticosteroid therapy in premature infants with bronchopulmonary dysplasia [abstract]. Pediatr Res 1990; 27:237A.
4. Brand PL, van Lingen RA, Brus F, Talsma MD, Elzenga NJ. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Paediatr 1993; 82:614-617.
5. Werner JC, Sicard RE, Hansen TW, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992; 120 (Pt 1):286-291.
6. Miranda-Mallea J, Perez-Verdu J, Gasco-Lacalle B, Saez-Palacios JM, Fernandez-Gilino C, Izquierdo-Macian I. Hypertrophic cardiomyopathy in preterm infants treated with dexamethasone. Eur J Pediatr 1997; 156:394-396.
7. Israel BA, Sherman FS, Guthrie RD. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 1993; 10:307-310.
8. La Mear NS, MacGilvray SS, Myers TF. Dexamethasone-induced myocardial hypertrophy in neonatal rats. Biol Neonate 1997; 72:175-180.
9. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M. Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 1994; 8:509-513.
10. Reller MD, Kaplan S. Hypertrophic cardiomyopathy in infants of diabetic mothers: an update. Am J Perinatol 1988; 5:353-358.
11. Gill AW, Warner G, Bull L. Iatrogenic neonatal hypertrophic cardiomyopathy. Pediatr Cardiol 1996; 17:335-339.